The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

13 Dec 2018 14:30

RNS Number : 4317K
Location Sciences Group PLC
13 December 2018
 

Prior to publication, this announcement contained inside information within the meaning of Article 7 of the EU Market Abuse Regulation 596/2014. With the publication of this announcement, this information is now considered to be in the public domain

13 December 2018

Location Sciences Group PLC

("Location Sciences" or the "Company")

Result of Open Offer

Highlights

· Gross proceeds of £188,748 raised in the Open Offer

· In aggregate, the Company has raised a total of £2.95 million in the Placing and Open Offer

· Net proceeds of the Placing and Open Offer to be used primarily to seek to deliver the potential of the Company's Verify product globally, particularly in the United States

 

Open Offer

Further to the Company's announcements of 26 November 2018, Location Sciences Group PLC (AIM: LSAI), a leading mobile location data intelligence company, announces that it has raised gross proceeds of £188,748 in the Open Offer, which closed for acceptances at 10.00 a.m. today. The Company received valid acceptances from Qualifying Shareholders in respect of 8,388,780 Open Offer Shares, including applications for 2,527,706 Open Offer Shares under the Excess Application Facility. This represents 40.0 per cent. of the maximum Open Offer Shares available under the Open Offer.

 

Admission and Total Voting Rights

Application has been made to the London Stock Exchange for the admission of the 8,388,780 Open Offer Shares to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 14 December 2018. The 8,388,780 Open Offer Shares will, on Admission, rank pari passu with the Company's existing Ordinary Shares. Following Admission, the Enlarged Share Capital will comprise 341,044,439 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Verify

The Company has now raised, in aggregate, £3.36 million (before expenses) since 14 June 2018. Location Sciences will use the net proceeds of the Placing and the Open Offer primarily to seek to deliver the potential of the Company's Verify product globally, particularly in the United States.

 

The Company successfully launched its platform 'Verify' earlier this year to combat location ad-fraud. Verify protects advertisers against location ad-fraud by ensuring their location-based adverts are delivered to their intended audiences.

 

Mark Slade, Chief Executive Officer, of Location Sciences, commented: "We are pleased to have raised a further £0.2 million through the Open Offer to further drive our leadership in ad location data verification. This is a significant milestone in the business and we would like to thank our shareholders for their continued support. We are excited for what 2019 has in store, as we continue to invest in our products, expand internationally and develop our team."

 

 

New investors who are seeking to apply for Enterprise Investment Scheme tax reliefs, can contact the Company for further information via the following email address: eis@locationsciences.ai

Save as defined herein, capitalised terms used in this announcement have the same meaning as in the Open Offer Circular, posted to Qualifying Shareholders on 27 November 2018.

For further information please contact:

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Stockdale Securities Limited

Tel: +44 (0)20 7601 6100

Tom Griffiths

 

Ed Thomas

 

 

 

 

Milk & Honey PR

 

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Harriet King

 

 

About Location Sciences Group PLC:

 

Location Sciences is a leading mobile location data intelligence company. Through its machine learning and pattern recognition expertise, Location Sciences provides its customers with a range of services, including location verification, online to offline attribution, out of home (OOH) solutions, location planning and consumer behaviour insights.

 

Verify is a bespoke solution built by Location Sciences to extract the full value of location-based advertising campaigns. Verify protects advertisers against location ad-fraud by ensuring their location-based adverts are targeting the right audiences. Through Verify, advertisers have access to real time insights into how their advertising campaigns are performing, enabling them to cut wastage and enhance effectiveness.

 

Location Sciences works in partnership with brands, agencies, OOH media owners and technology partners to extract the full value of mobile location data.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZMMMZDFZGRZM
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.